SQD Completes $4.2 Million Equity Financing

TORONTO, Apr 10, 2014 (Canada NewsWire via COMTEX) SQI Diagnostics Inc. ( SQI or the Company ) (TSX-V: SQD), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has closed its previously announced public offering (the Offering ). Pursuant to the Offering, SQI issued 8,400,000 units of the Company ( Units ) at a price of C$0.50 per Unit for gross proceeds of C$4.2 million. Each Unit is comprised of one common share of the Company (a Common Share ) and one Common Share purchase warrant (a Warrant ). Each Warrant is exercisable at a price of C$0.65 and entitles the holder thereof to acquire one Common Share until April 10, 2016. The Units were issued pursuant to an agency agreement the Company entered into with Euro Pacific Canada Inc. (the Agent ). H.C. Wainwright & Co., LLC and Kingsdale Capital Markets Inc. formed part of the selling group, and H.C. Wainwright & Co.,
http://www.publicwire.com/sqd-completes-4-2-million-equity-financing/